NASDAQ: SMTI - Sanara MedTech Inc.

Yield per half year: -12.69%
Dividend yield: 0%
Sector: Healthcare

Share chart Sanara MedTech Inc.


About Sanara MedTech Inc.

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States.

more details
It also offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

IPO date 2011-02-22
ISIN US79957L1008
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://sanaramedtech.com
Цена ао 35.1
Change price per day: 0% (30.88)
Change price per week: -4.54% (32.35)
Change price per month: +7.63% (28.69)
Change price per 3 month: -11.82% (35.02)
Change price per half year: -12.69% (35.37)
Change price per year: +1.21% (30.51)
Change price per 3 year: +37.24% (22.5)
Change price per 5 year: +185.93% (10.8)
Change price per year to date: -9.47% (34.11)

Underestimation

Title Value Grade
P/S 3.25 5
P/BV 7.24 1
P/E 0 0
EV/EBITDA -160.19 0
Total: 2.25

Efficiency

Title Value Grade
ROA, % -11.93 0
ROE, % -22.95 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.2329

Debt

Title Value Grade
Debt/EBITDA -17.35 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 455.59 10
Yield Ebitda, % -60.42 0
Yield EPS, % 49.04 6
Total: 5.2



Head Job title Payment Year of birth
Mr. Ronald T. Nixon Executive Chairman & CEO N/A 1956 (69 years)
Mr. Michael D. McNeil CFO & Corporate Secretary 438.68k 1965 (60 years)
Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D. President of Telehealth Services 156k 1970 (55 years)
Mr. Callon Nichols Vice President of Corporate Operations N/A
Mr. Bill Fitzgerald Chief Compliance Officer N/A
Ms. Tricia Matteson Vice President of Marketing N/A
Dr. Rebecca Erin Mcmahon President of Research & Development N/A 1985 (40 years)
Mr. Seth Yon President of Commercial N/A
Mr. Jacob A. Waldrop Chief Operating Officer
Mr. Tyler Palmer Chief Corporate Development & Strategy Officer

Address: United States, Fort Worth. TX, 1200 Summit Avenue - open in Google maps, open in Yandex maps
Website: https://sanaramedtech.com